Teru-MS 7 Tablet Uses Composition Dosage Sideeffects and Precautions

For informational purposes only.

Teru-MS 7

Teru-MS 7 tablet tablet is prescribed to adults for the treatment of recurrent form of multiple sclerosis (MS) (the symptoms of the disease appear from time to time).

Teru-MS 7 tablet Uses :-

Teru-MS 7 tablet is used for the treatment of relapsing-remitting form of multiple sclerosis in adults.

Multiple sclerosis is a disease of the brain and spinal cord. In which nerves do not function properly, their own immune system attacks the protective sheath (called myelin) of the nerves. And it causes nerve damage. This causes symptoms such as numbness, loss of vision, fatigue, pain and loss of muscle coordination.

Teru-MS 7 tablet works by limiting the function of specific immune cells that cause nerve damage in multiple sclerosis. In this way it prevents recurrence as well as slows down the progression of the disease.

Teru-MS 7 tablet helps to suppress the body's immune system, preventing the return of symptoms. Teriflunomide slows down the progression of the disease and also reduces the inflammation of the damaged nerves, preventing further damage. Stabilizes your immune system.

Teru-MS 7 tablet Composition :-

Teru-MS 7 tablet contains -

Teriflunomide .......................... 7 mg

Teriflunomide belongs to a class of drugs called immunomodulatory drugs.

Teru-MS 7 tablet Dosage Forms & Strengths :-

Teru-MS 7mg tablet for oral use.

Teru-MS 7 tablet Dosage :-

Teru-MS 7 tablet is a prescription medicine, & the dosage or duration is prescribed by the doctor according to the symptoms of the patients.

Teru-MS 7 tablet is taken with or without food. But, take it at the same time every day, usually once a day.

If you ever forget to take a dose, take it as soon as possible, if it is time for the next dose, skip the missed dose and take the dose at the regular time.

Teru-MS 7 tablet Sideeffects :-

Like all medicines, Teru-MS 7 tablet can cause side effects, however not everyone may experience these side effects.

Some common side effects like -

Diarrhea,

Nausea,

Increased ALT,

Hair loss,

Influenza,

Tingling or pricking sensation,

Phosphatemia and many other side effects can occur.

How Teru-MS 7 tablet ( Teriflunomide ) works:-

Teru-MS 7 tablet contains: Teriflunomide.

Teriflunomide -

Teriflunomide belongs to a class of drugs called immunomodulatory drugs.

Teriflunomide works by limiting the function of immune cells ( T and B cells ) that cause nerve damage in multiple sclerosis.

Teriflunomide works by limiting the function of specific immune cells that cause nerve damage in multiple sclerosis. In this way it prevents recurrence as well as slows down the progression of the disease.

Teriflunomide helps to suppress the body's immune system, preventing the return of symptoms. Teriflunomide slows down the progression of the disease and also reduces the inflammation of the damaged nerves, preventing further damage. Stabilizes your immune system.

Precautions :-

Teru-MS 7 tablet should not be used during pregnancy. Because it can harm the unborn baby.
Breastfeeding women should not use Teru-MS 7 tablet. As it can pass into breast milk consult your doctor.
Regular urine and blood tests to monitor blood cells, liver, and kidney function may be required during treatment with Teru-MS 7 tablet.
Before taking Teru-MS 7 tablet tell your doctor if you are allergic to teriflunomide.
If you,
Liver problems,
Blood disorders/bone marrow,
Immune system disorders (such as those caused by cancer, HIV infection),
Recent infection (eg tuberculosis),
High blood pressure,
Lung disease etc.
Teru-MS 7 tablet can make infections more likely or can worsen infections.

Teru-MS 7 tablet Price :-

MRP ₹ : 656.40 ( 10 tabs )

Packing Information :-

Teru-MS 7 tablet is available in pack of 10 tablets.

Teru-MS 7 tablet Marketed By :-

MSN Laboratories

Teru-MS 7 tablet Self life :-

Please see the expiry date/manufacture date printed on the Teru-MS 7 tablet pack.

Classification :-

Habit Forming - No

Drug - Teriflunomide

Therapeutic Class - Immunomodulatory, Multiple sclerosis,

Information on this page was last updated on 14 September 2021